Growth Investments

Providing growth capital to scalable life science companies

What we do

Growth Investments invests in scalable, high-growth life science companies that have reached, or are approaching the commercial stage and require capital for expansion and acceleration.

We focus on investments in life science tools and diagnostics, MedTech, life science services and healthcare technology.

Our combination of patient capital, deep sector expertise and global network positions us as a long-term partner to companies navigating growth in dynamic and often challenging market environments.

Strategy

We are an engaged investor and active partner to life science companies with strong fundamentals and differentiated technologies. Our investments focus primarily on life science tools and diagnostics, MedTech, healthcare IT and life science services.

We leverage our scientific insight, operational experience and international network to support management teams as they scale their organisations, expand into new markets and strengthen their platforms. Novo Holdings’ evergreen capital structure enables us to maintain a long-term perspective and support portfolio companies beyond traditional fund cycles.

Key figures

Currency
DKK

3

bn

Value of Investment Assets Portfolio

6

Number of portfolio companies

DKK

221

m

Deployed in 2025

Our Growth Investments Portfolio

Search

Meet our team

We are a dedicated growth equity team with strong industry and scientific knowledge and experience, based in San Francisco.